AdaptVac Company
AdaptVac aims to accelerate the development of safe and efficacious therapeutic and prophylactic vaccines to treat and prevent specific cancers, infectious diseases and immunological disorders. AdaptVac is currently focused on developing a COVID-19 vaccine.
Investor Type:
N/A
Technology:
COVID
Investment Stage:
N/A
Founded Date:
N/A
Industry:
Vaccine/Drug
Employee Number:
N/A
Funding Status:
N/A
Number Of Exists:
N/A
Headquarters:
Denmark